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Abstract. Yaws, a non-venereal treponemal disease, is targeted for eradication by 2020 but accurate epidemiologi-
cal data to guide control programs remain sparse. The Solomon Islands reports the second highest number of cases of
yaws worldwide. We conducted a cluster randomized survey of yaws in two provinces of the Solomon Islands. One
thousand four hundred and ninety-seven (1,497) children 5–14 years of age were examined. Clinical signs of active yaws
were found in 79 children (5.5%), whereas 140 children (9.4%) had evidence of healed yaws lesions. Four hundred and
seventy (470) (31.4%) children had a positive Treponema pallidum particle agglutination assay (TPPA). Two hundred
and eighty-five (285) children (19%) had a positive TPPA and rapid plasma regain assay. Risk of yaws increased with
age and was more common in males. The prevalence of yaws at village level was the major risk factor for infection. Our
findings suggest the village, not the household, should be the unit of treatment in the World Health Organization (WHO)
yaws eradication strategy.
INTRODUCTION
Yaws is a non-venereal, endemic treponemal infection
caused by Treponema pallidum pertenue1 and is closely
related to T.p. pallidum, the causative agent of venereal syph-
ilis.2 Unlike syphilis, yaws is generally a disease of children3
living in poor, rural settings and is found mostly in warm and
humid environments.4 Infection predominantly results in
lesions of the skin and bone.5 Tertiary yaws causes disfiguring
lesions of the face but neurological and cardiovascular mani-
festations (which can appear in advanced syphilis) are not
thought to occur. A major campaign in the 1950s was respon-
sible for a significant reduction in the prevalence of disease
worldwide, but following the dismantling of vertical control
programs, the number of cases subsequently rebounded, and
yaws now represents a significant public health problem in
Africa, South-East Asia, and the Pacific.6–10
In a single-center study in Papua New Guinea, azithromycin
was shown to be equivalent to benzathine-penicillin in the
treatment of both primary and secondary yaws.11 The discov-
ery of an orally effective agent prompted the World Health
Organization (WHO) to plan a renewed effort to eliminate
yaws using community mass treatment.12
Despite optimism, clinical and epidemiological data on
yaws remain sparse. Many countries report only clinical cases
without laboratory confirmation and there are inadequate
data to guide control programs in many countries. Previous
studies have shown that the majority of clinical cases occur in
children < 15 years of age, and have also suggested a prepon-
derance of cases in males.3,8,13 It is also recognized that for
every clinical case there are 5–6 individuals with serological
evidence of infection but no clinical manifestations.8,13
The Solomon Islands, a Pacific archipelago of ~100 inhabited
islands, is endemic for yaws, and in 2010 the country reported
20,635 cases of yaws, the second highest number of cases in the
world after Papua New Guinea, which lies immediately to the
north.5 We conducted a cluster randomized community survey
in two provinces of the Solomon Islands to establish the prev-
alence of yaws infection and disease, and to explore risk fac-
tors associated with infection and disease at community level.
MATERIALS ANDMETHODS
Participant recruitment. The study was undertaken in
Western and Choiseul Provinces of the Solomon Islands in
September and October 2013, alongside programmatic tra-
choma mapping activities.14 The two provinces were consid-
ered as two separate evaluation units. We defined clusters
either as villages or as groups of villages to obtain 50 clusters
of approximately equal size. Twenty-five clusters were
selected at random in each province. In each cluster, a com-
plete census of all households was obtained and 30 house-
holds were selected using simple random sampling. In
selected households children 5–14 years of age were invited
to participate. Where selected households were unoccupied,
an alternative household was randomly selected. Written
informed consent was obtained from the head of each house-
hold by staff fluent in the local dialect. Assent was obtained
from all children. We calculated that a sample size of 1,022
would allow us to detect a prevalence of infection of 10% with
absolute precision of 3% assuming a design effect of 2.5.
Data collection. Household-level data were collected on
location (recorded using the smartphone global positioning
system) and Water, Sanitation and Hygiene (WASH) vari-
ables, including source of water and the presence or absence
of hand washing facilities and latrines.
Participant-level data were collected on demographics and
clinical features of yaws. The survey team completed a stan-
dardized history and examination, collecting information on
bone and joint symptoms, yaws treatment history, and the
number, location, and duration of skin lesions. Skin lesions
were classified using the WHO pictorial yaws classification
scheme. All data were collected using the LINKS software
package on Android smartphones.15
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The survey team performed venipuncture on all individuals,
regardless of clinical features, and obtained a serum sample
for diagnostic testing. Samples were transferred to the National
Referral Hospital in Honiara where they were frozen. Samples
were transferred on dry ice for diagnostic testing at the London
School of Hygiene & Tropical Medicine (LSHTM).
Laboratory studies. Sera were tested using both the Trepo-
nema pallidum particle agglutination assay (TPPA, Mast Diag-
nostics, Merseyside, UK) and a quantitative rapid plasma regain
test (RPR, Deben Diagnostics, Ipswich, UK), at LSHTM, by an
operator masked to clinical findings.
Ethics. Ethical approval for the study was granted by the
ethics committees of the Ministry of Health and Medical Ser-
vices in the Solomon Islands (HRC 13/10) and LSHTM (6358)
in the UK.
Diagnosis. A positive TPPA was taken as evidence of pre-
vious or current infection. A positive TPPA combined with a
quantitative RPR titer of ³ 1/4 was taken to represent dual-
positive serology, suggestive of active infection. Individuals
with a single ulcerative or papillomatous lesion and dual-
positive serology were considered to have primary yaws. Indi-
viduals with skin or bony lesions consistent with secondary yaws
and dual-positive serology were considered to have secondary
yaws. Individuals with late manifestations (gondou, gangosa,
or gummatous lesions) would have been considered to have
tertiary yaws. Individuals with dual-positive serology but no
current clinical signs were considered to have latent yaws.
Analyses. Logistic regression was used to estimate unad-
justed and adjusted odds ratios (ORs) for factors associated
with both TPPA positivity or dual seropositivity. We classi-
fied household size as less than or greater than the national
average (5 residents) according to the 2009 census. There are
no established criteria for classifying yaws endemicity based
on serological findings. We adjusted previous treatment
criteria, based on the number of clinical cases,3 by a factor of
5 to accommodate individuals with latent infection. For the
purpose of analysis villages were classified as hypo-endemic
(0–25% of surveyed individuals dual seropositive), meso-
endemic (26–50% of individuals dual seropositive), or hyper-
endemic (> 50% of individuals dual seropositive). Robust
standard errors were used to calculate all confidence intervals
(CIs) and P values to account for village-level clustering.
All analyses were performed using Stata 13.1 (StataCorp,
College Station, TX).
RESULTS
Clinical findings. One thousand four hundred and ninety-
four (1,494) households in 981 villages were visited; there was
no-one home, or no residents 5–14 years of age, in 656 house-
holds. One thousand four hundred and ninety-seven (1,497)
children were enrolled from 98 villages and 838 households
(Figure 1). Demographic data on these individuals are
shown in Table 1. More children were enrolled in Western
province (N = 889) than Choiseul province (N = 608). Skin
lesions, of any type, were found in 290 children (19.4%, 95%
CI 14.3–25.6%).
In total, clinical signs suggestive of active yaws were found
in 79 (5.5%, 95% CI 4.0–7.5%) children. Of these, 50 children
(3.3%, 95% CI 2.4–4.6%) had skin lesions consistent with
primary yaws, whereas 29 (2.0%, 95% CI 1.1–3.7%) had
signs consistent with secondary yaws. Skin lesions consistent
with secondary yaws were found in 19 (1.3%, 0.6–2.9%),
bone lesions consistent with secondary yaws were found in
Figure 1. Map showing locations of surveyed villages. Villages where the seroprevalence of yaws was 0–25% (hypo-endemic), 25–50% (meso-
endemic), and > 50% (hyper-endemic) are shaded green, yellow, and red, respectively. The predominance of coastal villages reflects the
distribution of communities within the Solomon Islands.
Table 1
Demographics
Western Province Choiseul Province
Number of children 889 (59.4%) 608 (40.6)
Number of households 494 344
Number of villages 45 53
Number clusters 25 25
Age (median, IQR) 9 (7–12) 9 (7–11)
Male 438 (49.3%) 323 (53.1%)
Household size (median, IQR) 5 (4–6) 5 (4–6)
Number positive TPPA individuals 334 (37.6%) 132 (21.9%)
Number dual seropositive individuals 186 (20.9%) 63 (10.4%)
Village classified as endemic 12 (26.7%) 3 (5.7%)
Village classified as highly endemic 4 (8.9%) 2 (3.8%)
Access to hand washing facilities 137 (15.4%) 52 (8.6%)
IQR = interquartile range; TPPA = Treponema pallidum particle agglutination.
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10 (0.7%, 95% CI 0.3–1.5%) children. One hundred and forty
(140) children (9.4%, 95% CI 6.1–14.1%) had evidence of
healed yaws lesions, of whom 7 also had evidence of active
yaws. Two hundred and eighteen (218) children (15.2%, 95%
CI 11.0–20.5%) reported treatment of yaws in the last
12 months.
Serological findings. Four hundred and seventy children
(470) had a positive TPPA, giving a seroprevalence of previ-
ous or current treponemal infection of 31.4% (95% CI 23.6–
41.5%). As expected, the prevalence of TPPA positivity
increased with age (Figure 2). In Western province, seroprev-
alence was 37.6% (95% CI 28.1–51.1%), as compared with
21.7% (95% CI 10.4–40.2%) in Choiseul province; after
adjustment for clustering this difference was not statistically
significant (P < 0.09).
Of individuals with a positive TPPA, 285 (60.6%) had an
RPR ³ 1/4, suggesting active treponemal infection. Dual sero-
positivity was therefore 19.0% overall, but varied significantly
between Western Province (N = 186, 21.7%, 95% CI 14.6–
30.9%) and Choiseul Province (N = 63, 10.4%, 95% CI 4.1–
24.2%) (P = 0.11).
Twenty-four (30.4%) of 79 children with signs of active
yaws and 40 (28.6%) of 140 children with signs of healed yaws
were dually seropositive, compared with 14.8% of children
without signs of active or healed yaws (P < 0.01 for both
comparisons) (Table 2).
Based on serology data we classified 77 (78.6%) villages as
non-endemic, 15 (15.3%) villages as endemic, and 6 (6.1%)
villages as highly endemic. Eighty percent of dual-serologically
positive individuals lived in a meso-endemic or hyper-
endemic village.
Risk factors. In both unadjusted and adjusted analyses, age,
sex, number of dual seropositive household contacts, degree
of village endemicity, and access to hand washing facilities
were all associated with both TPPA positivity and dual sero-
positivity, and active disease. Household size was not a risk
factor for either infection or active disease (Tables 3 and 4).
DISCUSSION
This study confirms that yaws is endemic in the north-west
of the Solomon Islands, with one-third of children in this area
showing evidence of infection by TPPA. In keeping with
national case reporting, we observed a difference in the prev-
alence of clinical signs of yaws and of both TPPA positivity
and dual seropositivity between Western and Choiseul prov-
inces, although this result was not statistically significant after
accounting for clustering. As anticipated, there was significant
clustering of both infection and disease. The degree of ende-
micity at village level was the strongest risk factor for both
TPPA positivity and dual seropositivity, a finding that sug-
gests communities, not households, should be the target of
contact tracing and treatment as part of the WHO yaws erad-
ication campaign in this population. Treatment failure with
penicillin has previously been reported to be associated with
the degree of endemicity at village level.16 Our data support
the theory that reinfection, rather than true treatment failure,
may partially explain this finding.
Seropositivity was strongly associated with the number of
seropositive household contacts. It is possible that this associ-
ation is a consequence of transmission to household contacts
from an actively infected individual rather than a risk factor
for initial infection per se. Longitudinal data would be needed
to better explore this association.
Figure 2. Seroprevalence by age prevalence (and 95% confidence
interval [CI]) of Treponema pallidum particle agglutination (TPPA)
assay and dual seropositivity (TPPA and rapid plasma regain [RPR]
titer ³ 1/4) by age group.
Table 2
Serology results
Overall Western Province Choiseul Province
Clinical evidence of primary yaws n 50 38 12
TPPA positive/RPR negative 1 (2%) 1 (2.6%) 0 (0%)
TPPA positive/RPR < 1/4 3 (6%) 2 (5.3%) 1 (8.3%)
TPPA positive/RPR ³ 1/4 17 (34%) 11 (29.0%) 6 (50%)
Clinical evidence of secondary yaws N 29 28 1
TPPA positive/RPR negative 2 (6.9%) 2 (7.1%) 0 (0%)
TPPA positive/RPR < 1/4 3 (10.3%) 3 (10.7%) 1 (0%)
TPPA positive/RPR ³ 1/4 7 (24%) 6 (21.4%) 1 (100%)
Clinical evidence of previous yaws N 140 135 5
TPPA positive/RPR negative 21 (15%) 21 (15.6%) 0 (0%)
TPPA positive/RPR <1/4 25 (17.9%) 24 (17.8%) 1 (20%)
TPPA positive/RPR ³1/4 40 (28.6%) 40 (29.6%) 0 (0%)
No clinical evidence of active yaws N 1278 688 590
TPPA positive/RPR negative 59 (4.6%) 28 (4.1%) 31 (5.3%)
TPPA positive/RPR < 1/4 122 (9.5%) 75 (10.8/%) 47 (8.0%)
TPPA positive/RPR ³ 1/4 188 (14.8%) 132 (19.2%) 56 (9.5%)
TPPA = Treponema pallidum particle agglutination; RPR = rapid plasma regain.
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As in previous studies, there were several individuals with
serological evidence of infection for every individual with
clinically apparent disease,8,13 and a large number of individ-
uals with typical skin lesions who were not dually seroposi-
tive.17 Lesions not associated with positive serology may
reflect early yaws before conversion, recent treatment of yaws
with declining RPR titers, misclassification of the lesion by
survey personnel, or alternative aetiologies of ulcerative skin
lesions.Haemophilus ducreyi has recently been identified as a
possible causative agent of yaws-like lesions in the Pacific
region.18–20
As expected, the prevalence of TPPA positivity increased
with age within the age group examined, and the study also
confirmed previous reports8,13 that males are at slightly higher
risk than females of both TPPA positivity and dual seroposi-
tivity. The reasons for this association are unclear. It is possi-
ble that the association with gender reflects an earlier onset of
sexual intercourse in boys than girls, with misclassification of
cases of syphilis as yaws in endemic communities. In our
study, the association with gender remained when analyses
were restricted to children < 10 years of age, making this kind
of misclassification less likely.
An unexpected finding was the protective association
between access to hand washing facilities and the risk of
TPPA positivity and dual seropositivity. It is thought that
yaws is spread by skin-to-skin contact when bacteria from a
lesion enter by a breach in the skin.3,21 It is plausible that
access to hand washing facilities promotes better overall skin
health, reducing the number of small abrasions and lesions,
which might serve as portals of entry for T. pallidum ssp.
pertenue. It is also possible that this association is explained
by residual confounding, from better general living conditions
or access to health care facilities.
Although we did not examine adults during this survey, we
did not see any cases of tertiary yaws in the communities we
visited, a finding in keeping with a previous yaws survey in the
Table 3
Risk factors for TPPA positivity
Illustrative prevalence data Unadjusted OR Adjusted OR
Age (years)* 5–9: 27.0%
10–14: 37.9%
1.14 (1.08–1.20) P < 0.001
Sex Male: 35.1%
Female: 28.6%
1.35 (1.11–1.64) P = 0.002
Household size £ 5: 29.8%
> 5: 35.6%
1.30 (0.90–1.88) P < 0.160
Number of household dual
seropositive contacts†
0 22.9%
1 69.1% 7.52 (4.72–12.0) P < 0.001 3.92 (2.16–7.12) P < 0.001
> 1 86.1% 20.80 (9.25–46.76) P < 0.001 10.74 (4.38–26.37) P < 0.001
Household dual seropositive
contacts with skin ulcers‡
Absent: 30.7%
Present 82.4%
10.54 (3.43–32.33) P < 0.001 7.52 (4.72–12.0) P < 0.001
Village§ Hypo-endemic 14.5%
Meso-endemic 67.0% 12.02 (6.99–20.68) P < 0.001 10.22 (6.35–16.42) P < 0.001
Hyper-endemic 74.2% 17.01 (9.50–30.46) P < 0.001 20.51 (12.11–34.75) P < 0.001
Hand washing facilities¶ Absent 33.2%
Present: 23.4%
0.62 (0.35–1.09) P = 0.095 0.62 (0.35–1.09) P = 0.095
*Relative increase in odds per year increase in age.
†TPPA positive with a reactive RPR titer ³ 1/4. Adjusted for age, gender, household size, and village endemicity.
‡TPPA positive with a reactive RPR titer ³ 1/4 and an ulcerative skin lesion. adjusted for age, gender, household size, and village endemicity.
§Adjusted for age, gender, household size, and household contacts.
¶Hand washing facilities reported by family within 15 m of toilet/latrine. Adjusted for age, gender, and household size.
OR = odds ratio; TPPA = Treponema pallidum particle agglutination; RPR = rapid plasma regain.
Table 4
Risk factors for dual seropositivity
Unadjusted OR Adjusted OR
Age* 5–9: 15.4%
10–14:19.1%
1.08 (1.02–1.14) P = 0.006 1.08 (1.03–1.14) P = 0.003
Sex Male: 19.5%
Female: 14.4%
1.44 (1.38–1.83) P = 0.002 1.48 (1.17–1.88) P = 0.001
Household size £ 5: 16.0%
> 5: 18.9%
1.22 (0.79–1.90) P = 0.362
Number of household dual
seropositive Contacts†
0 9.9%
1 46.4% 7.85 (4.12–14.97) P < 0.001 4.18 (2.12–8.25), P < 0.001
> 1 59.3% 13.20 (6.40–27.21) P < 0.001 6.74 (2.72–16.70), P < 0.001
Household dual seropositive
contacts with skin ulcers‡
Absent: 16.2%
Present: 52.9%
5.82 (2.57–13.21) P < 0.001 7.52 (4.72–12.0) P < 0.001
Village§ Non-endemic 4.95%
Endemic 40.11% 12.85 (7.17–23.02) P < 0.0001 8.30 (5.36–12.86) P < 0.001
Highly endemic 51.6% 20.46 (10.79–38.82) P < 0.0001 20.33 (11.88–34.80) P < 0.001
Hand washing facilities¶ Absent: 18.4%
Present: 8.0%
0.39 (0.16–0.90) P = 0.029 0.39 (0.16–0.91) P = 0.029
*Increase in odds per year increase in age.
†TPPA positive with a reactive RPR titer ³ 1/4. Adjusted for age, gender, household size, and village endemicity.
‡Adjusted for age, gender, household size, and village endemicity.
§TPPA positive with a reactive RPR titer ³ 1/4 and an ulcerative skin lesion. adjusted for age, gender, household size, and village endemicity.
¶Hand washing facilities reported by family within 15 m of toilet/latrine. Adjusted for age, gender, and household size.
TPPA = Treponema pallidum particle agglutination; RPR = rapid plasma regain.
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Solomon Islands.17 The reasons why late stage manifestations
are less common than previously reported are unclear, but
improved access to health care and use of antibiotics with
treponemocidal activity for other infections may partially
account for this finding.
In summary, our data confirm that yaws is highly endemic
in the Solomon Islands. Our study confirms previously sug-
gested associations between gender and infection while also
highlighting the need for further studies to examine the asso-
ciation with access to hand washing facilities. Prevalence of
disease at a village level was shown to be the major risk factor
for disease at an individual level, a finding that suggests the
community should be the unit of treatment in response to the
identification of cases of yaws, in the WHO yaws eradication
strategy.12 Further studies are needed to investigate whether
the associations shown in this study remain after community
mass treatment with azithromycin.
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